P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression

By Coronado P.J.   Vidart J.A.   Lopez-asenjo J.A.   Fasero M.   Furio-bacete V.   Magrina J.   Escudero M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 98, Iss. 1, 2001-09 ,pp. : 103-108

Elsevier

Access to resources Recommend Favorite

Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor

By Meden H.   Kuhn W.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 71, Iss. 2, 1997-02 ,pp. : 173-179

Elsevier

Access to resources Recommend Favorite

Modulation of expression of p53 and cell proliferation in locally advanced cervical carcinoma after neoadjuvant combination chemotherapy

By Garzetti G.G.   Ciavattini A.   Lucarini G.   Goteri G.   De Nictolis M.   Romanini C.   Biagini G.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 63, Iss. 1, 1995-11 ,pp. : 31-36

Elsevier

Access to resources Recommend Favorite

The effects of ischaemic preconditioning on ovarian apoptosis and p53 expression during laparoscopy

By Arioz D. T.   Tosun M.   Polat C.   Saylan A.   Yilmazer M.  

Journal of Obstetrics & Gynaecology, Vol. 32, Iss. 5, 2012-07 ,pp. : 467-471

Informa Healthcare

Access to resources Recommend Favorite

A huge abdominal mass mimicking ovarian cancer: p53-negative but aneuploid myxoid leiomyosarcoma of the uterus

By Kaleli S.   Calay Z.   Ceydeli N.   Aydynly K.V.   Kosebay D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 100, Iss. 1, 2001-12 ,pp. : 96-99

Elsevier

Access to resources Recommend Favorite